PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Wheaton Precious Metals Corp. (WPM)
96.701.20 (1.26%)
95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-15.06%
Negative revenue growth while OR stands at 9.92%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-15.06%
Negative gross profit growth while OR is at 10.18%. Joel Greenblatt would examine cost competitiveness or demand decline.
-1735.83%
Negative EBIT growth while OR is at 15.15%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1735.83%
Negative operating income growth while OR is at 7.56%. Joel Greenblatt would press for urgent turnaround measures.
-3021.48%
Negative net income growth while OR stands at 26.20%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-2983.33%
Negative EPS growth while OR is at 21.43%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-2983.33%
Negative diluted EPS growth while OR is at 21.43%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1836.26%
Negative OCF growth while OR is at 11.49%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-1836.26%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-10.91%
Negative 10Y revenue/share CAGR while OR stands at 191.83%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-10.91%
Negative 5Y CAGR while OR stands at 29.95%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-10.91%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.40%
AR growth well above OR's 8.62%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.46%
Inventory growth of 6.46% while OR is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-26.32%
Negative asset growth while OR invests at 3.85%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-26.93%
We have a declining book value while OR shows 5.86%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.28%
We cut SG&A while OR invests at 19.74%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.